Novartis AG (NVSEF) Dividends paid 2016–2025
Novartis AG (NVSEF) annual cash dividends paid, per SEC filings (common; includes preferred where a filer reports only the combined figure).
$7.8BFY2025 · since FY2016: $6.5B → $7.8B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.8B | +2.5% |
| FY2024 | $7.6B | +5.1% |
| FY2023 | $7.3B | -3.3% |
| FY2022 | $7.5B | +1.9% |
| FY2021 | $7.4B | +5.5% |
| FY2020 | $7.0B | +5.1% |
| FY2019 | $6.6B | -4.6% |
| FY2018 | $7.0B | +7.3% |
| FY2017 | $6.5B | +0.3% |
| FY2016 | $6.5B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More NVSEF financial trends
NVSEF RevenueNVSEF Net incomeNVSEF Net marginNVSEF Gross profitNVSEF Gross marginNVSEF Operating incomeNVSEF Operating marginNVSEF Operating cash flowNVSEF Free cash flowNVSEF Capital expendituresNVSEF Return on equityNVSEF Stock buybacksNVSEF Total assetsNVSEF Total liabilitiesNVSEF Shareholders’ equityNVSEF overview →